Lmwx 20 (Enoxaparin Sodium PFS) 20mg/0.2ml

LMWX 20 contains enoxaparin sodium, a low molecular weight heparin used for blood clot prevention. This 20mg/0.2ml prefilled syringe offers convenient anticoagulation therapy. Store below 25°C to maintain stability and efficacy. Ideal for short-term clot management needs.

Strength

20mg/0.2ml

Pack Size

10s

Storage

Below 25°C

Manufacturer / TM Owner

Virchow Biotech Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

LMWX 20 is used to prevent blood clots in patients undergoing certain surgeries or medical procedures. It may also be prescribed for patients with unstable angina or non-Q-wave myocardial infarction. The medication helps reduce the risk of deep vein thrombosis and pulmonary embolism. Patients with limited mobility may benefit from its anticoagulant properties.

Side Effects

LMWX 20 works by enhancing the natural anticoagulant activity of antithrombin in the blood. This helps prevent the formation of harmful blood clots while allowing normal clotting to occur when needed. The prefilled syringe format allows for precise dosing and easy administration at home or in clinical settings.

Precautions & Warnings

LMWX 20 should be handled with care to avoid accidental needle sticks. Keep the product in its original packaging until ready for use. Do not use if the solution is discolored or contains particles. Always follow healthcare provider instructions for proper disposal of used syringes.

Avoid Interactions

LMWX 20 may interact with other blood thinners, NSAIDs, or medications affecting platelet function. Alcohol consumption should be avoided during treatment. Certain herbal supplements like ginkgo biloba may increase bleeding risk. Always inform your healthcare provider about all medications being taken.

Frequently Asked Questions

LMWX 20 is used to prevent blood clots in patients undergoing surgeries or with certain heart conditions.

Store LMWX 20 below 25°C in its original packaging until ready for use.

LMWX 20 may be administered at home after proper training from a healthcare professional.

Common effects may include bruising at the injection site or mild bleeding.

LMWX 20 should only be used during pregnancy under direct medical supervision.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.